Abstract
Chronic obstructive pulmonary disease (COPD) affects over 10% of the adult population worldwide and is currently projected to become the third leading cause of death by year 2030 [1]. We believe, COPD should be viewed as a multisystem disorder with clearly identified extra-pulmonary manifestations including weight loss, myopathy, cardiovascular diseases, diabetes, malignancies, bone mineral disease and psychological disorders. Most of these comorbidities are also important not only to understand the burden of this progressive disease, but also to devise effective therapeutic strategies [2]. This article reviews the current understanding of the systemic manifestations of COPD, which includes everything except airflow obstruction, emphysema and chronic bronchitis. For colleagues interested in reviewing the main component of COPD therapy, we urge to review an excellent article published in American Journal of Respiratory Critical Care Medicine volume 187, page 337- 365, Feb 15, 2013.
Keywords: Airflow obstruction, chronic bronchitis, COPD, pneumonia, pulmonary disease, pulmonary venous thrombo-embolism.
Current Respiratory Medicine Reviews
Title:COPD Evaluation: Beyond the Airway Obstruction, a Follow Up
Volume: 9 Issue: 2
Author(s): Asif Najmuddin, Naga Sirikonda and Harakh V. Dedhia
Affiliation:
Keywords: Airflow obstruction, chronic bronchitis, COPD, pneumonia, pulmonary disease, pulmonary venous thrombo-embolism.
Abstract: Chronic obstructive pulmonary disease (COPD) affects over 10% of the adult population worldwide and is currently projected to become the third leading cause of death by year 2030 [1]. We believe, COPD should be viewed as a multisystem disorder with clearly identified extra-pulmonary manifestations including weight loss, myopathy, cardiovascular diseases, diabetes, malignancies, bone mineral disease and psychological disorders. Most of these comorbidities are also important not only to understand the burden of this progressive disease, but also to devise effective therapeutic strategies [2]. This article reviews the current understanding of the systemic manifestations of COPD, which includes everything except airflow obstruction, emphysema and chronic bronchitis. For colleagues interested in reviewing the main component of COPD therapy, we urge to review an excellent article published in American Journal of Respiratory Critical Care Medicine volume 187, page 337- 365, Feb 15, 2013.
Export Options
About this article
Cite this article as:
Najmuddin Asif, Sirikonda Naga and Dedhia V. Harakh, COPD Evaluation: Beyond the Airway Obstruction, a Follow Up, Current Respiratory Medicine Reviews 2013; 9(2) . https://dx.doi.org/10.2174/1573398X113099990002
DOI https://dx.doi.org/10.2174/1573398X113099990002 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Metabolic Profiling in Disease Diagnosis, Toxicology and Personalized Healthcare
Current Pharmaceutical Biotechnology Mechanisms Involved in the Genesis of Diabetic Nephropathy
Current Diabetes Reviews Editorial [Hot Topic: Efficient Strategies for Signalling Pathway Mining (Guest Editors: Qingfeng Chen & Baoshan Chen)]
Current Protein & Peptide Science Lipid Nanocarriers and Molecular Targets for Malaria Chemotherapy
Current Drug Targets The Mediterranean and other Dietary Patterns in Secondary Cardiovascular Disease Prevention: A Review
Current Vascular Pharmacology Optimization of Cardiac Metabolism in Diabetes Mellitus
Current Pharmaceutical Design The Double Roles of the Prostaglandin E<sub>2</sub> EP2 Receptor in Intracerebral Hemorrhage
Current Drug Targets Heart Rate Lowering by Inhibition of the Pacemaker Current: A New Therapeutic Perspective in Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Atenolol: Differences in Mode of Action Compared with other Antihypertensives.An Opportunity to Identify Features that Influence Outcome?
Current Pharmaceutical Design Cardiovascular Disease and Diabetes in South Asians: The Twin Epidemic
Current Diabetes Reviews Multiple Mechanisms of Cytokine Action in Neurodegenerative and Psychiatric States: Neurochemical and Molecular Substrates
Current Pharmaceutical Design Changes in the Expression of the Alzheimers Disease-Associated Presenilin Gene in Drosophila Heart Leads to Cardiac Dysfunction
Current Alzheimer Research Hypertension and Angiogenesis
Current Pharmaceutical Design Mitochondrial Aldehyde Dehydrogenase, A Potential Drug Target for Protection of Heart and Brain from Ischemia/Reperfusion Injury
Current Drug Targets Therapeutic Approaches for Reducing C-Reactive Protein (CRP) Levels and the Associated Cardiovascular Risk
Current Chemical Biology Heat Shock Proteins: Mediators of Atherosclerotic Development
Current Drug Targets Patent Selections
Recent Patents on Biomarkers Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
Reviews on Recent Clinical Trials Preface (Hot Topic: Medicinal Strategies in the Treatment of Obesity Guest Editor: Akio Inui)
Current Medicinal Chemistry - Central Nervous System Agents Transdermal Delivery of Captopril and Metoprolol Tartrate with Microneedles
Drug Delivery Letters